Corticosteroids use and neurocognitive functioning in patients with recurrent glioblastoma: Evidence from European Organization for Research and Treatment of Cancer (EORTC) trial 26101.

Neurooncol Pract · 2022 · PMC9290884 · PMID 35855458

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

As life expectancy in patients with recurrent glioblastoma is short, maintaining NCF is a highly significant treatment goal both for patients and their caregivers. 10 NCF deficits are related to patients’ limitations to perform activities of daily living (ADL), inability to return to work, and financial difficulties.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.